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Rejection by Cellular and Functional
Cardiac Magnetic Resonance
Yijen L. Wu, PHD, Qing Ye, MD, Kazuya Sato, MD, Lesley M. Foley, BS,
T. Kevin Hitchens, PHD, Chien Ho, PHD
Pittsburgh, Pennsylvania
O B J E C T I V E S We sought to use cardiac magnetic resonance (CMR) to establish sensitive and
reliable indexes for noninvasive detection of acute cardiac allograft rejection.
B A C KG ROUND Appropriate surveillance for acute allograft rejection is vitally important for graft
survival. The current gold standard for diagnosing and staging rejection after organ transplantation is
endomyocardial biopsy, which is not only invasive but also prone to sampling errors. The motivation of
this study is to establish a CMR-based alternative that is noninvasive and sensitive for early detection of
allograft rejection before irreversible damage occurs.
METHOD S We employed a noninvasive 2-pronged approach to detect acute cardiac allograft
rejection using a rodent working heart and lung transplantation model. We used CMR to detect
immune-cell inﬁltration at sites of rejection by monitoring the accumulation of dextran-coated
ultra-small superparamagnetic-iron-oxide–labeled immune cells (in particular macrophages) in vivo.
Simultaneously, we used CMR tagging and strain analysis to detect regional myocardial function loss
resulting from acute rejection.
R E S U L T S Immune cells inﬁltration, mainly macrophages and monocytes, could be identiﬁed with
CMR by in vivo labeling with ultra-small superparamagnetic-iron-oxide. Our data show that immune-cell
inﬁltration in cardiac allograft rejection was highly heterogeneous. Thus, it is not surprising to ﬁnd
inconsistencies between rejection and endomyocardial biopsy results because of the limited number
and small samples available. Tagged CMR and strain analysis showed that, as with immune-cell
inﬁltration, ventricular functional loss was also heterogeneous. Although changes in global systolic
function were generally not observed until the later stages of rejection, our data revealed that a
functional index derived from local strain analysis correlated well with rejection grades, which may be
a more sensitive parameter for detecting early rejection.
CONC L U S I O N S CMR is noninvasive and provides a 3-dimensional, whole-heart perspective of the
rejection status, potentially allowing more reliable detection of acute allograft rejection. (J Am Coll
Cardiol Img 2009;2:731–41) © 2009 by the American College of Cardiology Foundation
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732ith the advances in immunosuppres-
sive therapy and organ preservation,
survival rate and quality of life after
heart transplantation have improved
onsiderably. Although decreased from the early
980s, acute cellular rejection still occurs in 40% to
0% of patients during the first 6 months following
urgery (1) and remains a challenge for battling
ortality (2). The occurrence of acute rejection
pisodes often is the most predictive factor for the
ater development of chronic rejection. Therefore,
he development of new, accurate, and noninvasive
ethods for monitoring of acute allograft rejection
fter heart transplantation is of vital importance.
See page 742
Acute rejection is traditionally diagnosed by en-
omyocardial biopsy, which carries finite risks of
orbidity and mortality due to its invasive nature,
and is also prone to sampling error because
of the limited sizes and locations of tissue
available, particularly in pediatric patients.
More importantly, discrepancies have
been found between biopsy-based diagno-
sis and actual rejection (3–6). Humoral
rejection, which accounts for most of the
biopsy-negative episodes of rejection (7),
is associated with accelerated graft coro-
nary artery disease, increased graft loss,
and increased mortality. The discordance
among biopsy, actual rejection, and pa-
tient outcome demands a reliable and
oninvasive alternative to biopsy for detecting acute
ejection.
Uncoupling the threshold for antirejection ther-
py from histological biopsy grading and linking it
ore closely to graft dysfunction has been sug-
ested (6,8). However, commonly used imaging
odalities, such as 2-dimensional echocardiogra-
hy and nuclear imaging, are relatively insensitive
o subtle changes in cardiac function. Functional
hanges resulting from acute rejection usually are
arely detectable by these methods until later rejec-
ion stages, when it may be too late for therapeutic
ntervention.
The goal of this study is to develop noninvasive
maging methodology to better detect early-stage
ejection before the development of irreversible
rgan damage. Our laboratory has implemented a
wo-pronged approach with cardiac magnetic reso-
ance (CMR) to noninvasively monitor both
demmune-cell infiltration and cardiac function of the eejecting grafts simultaneously. Immune cells, par-
icularly macrophages, are tracked with CMR by
abeling them with dextran-coated ultra-small
uperparamagnetic-iron-oxide (USPIO) nanopar-
icles in vivo (9–13). Cardiac tagging and strain
nalysis are used to evaluate small regional func-
ional changes during the rejection process.
ETHODS
nimals
ll rats used in the study were male inbred Brown
orway (BN) (RT1n) and Dark Agouti (DA)
RT1a) rats obtained from Harlan (Indianapolis,
ndiana) with body weights between 180 and 250 g.
he rats were housed individually and provided
ith food and water ad libitum. Animal protocols
ere approved by our Institutional Animal Care
nd Use Committee. All animals received humane
are in compliance with the Guide for the Care and
se of Laboratory Animals, published by the Na-
ional Institutes of Health.
In this study, 6 naïve BN rats were used for native
eart controls. For the transplantation models, 20
at transplantation pairs were used for experimental
llograft hearts, and 13 rat transplantation pairs
ere used for isograft controls.
nimal Model
his study employs a novel rodent heterotopic
orking heart and lung model (Fig. 1B) using a
A¡BN transplantation pair (10,11), with
A¡DA and BN¡BN transplantation as the
yngeneic control. The recipient receives an addi-
ional heart and lung in the abdomen. While the
ative organs support life, the entire rejection pro-
ess of the grafts can be investigated without serious
ystemic physiological alteration or mortality of the
ecipient from severe rejection. Although appropri-
te for studying immunological aspects of rejection,
he single-anastomosis model (Fig. 1A) used in our
arlier studies (12) is not suitable for functional
nvestigation, due to insufficient loading, via gurgi-
ation only. The double-anastomosis working
eart model (Fig. 1B) used in this study preserves
ntact pulmonary circulation and physiological
ressure and volume loading by partially ligating
he proximal end of the inferior vena cava.
lthough stroke volume may vary, ejection fraction
s near 100%, and isografts exhibit left ventricle
LV) strains similar to native hearts (Fig. 2). The
ay of transplantation surgery is day 0. HistologicalB B R E V I A T I O N S
N D A C R O N YM S
N Brown Norway rats
MR cardiac magnetic
esonance
A Dark Agouti rats
cc circumferential strains
V left ventricle
SPIO ultra-smallxamination (Fig. 3) shows that allografts exhibit
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733rade II rejection on post-operational days 4 to 5,
rade III rejection on post-operational days 5 to 6,
nd severe grade IV rejection on post-operational
ay 7.
n vivo labeling of USPIO. Dextran-coated USPIO
articles are synthesized in our laboratory according
o published methods (14,15) with slight modifica-
ions (16). The USPIO particles (27 nm in size)
re administered intravenously 1 day before CMR
Figure 1. Abdominal Heterotopic Transplanted Heart and Lung
Schematic drawings of (A) nonloading heart model and (B) biventri
ﬂow. Both models preserve all 4 heart chambers intact, yet the sing
only, whereas the double-anastomosis model (B) receives the prope
abdominal aorta. AAo  recipient abdominal aorta; LA  left atrium
RV  right ventricle.
Figure 2. Temporal Courses of Strains for Native and Isograft H
Temporal changes of circumferential strains (Ecc) (solid lines, all ne
values) strains for 3 native hearts (A, B, C) and 3 isografts (D, E, F)yellow).ith the dosage ranging from 1.5 to 3 mg iron per
nimal.
n vivo CMR. Rats were first sedated with isoflurane,
hen intubated and ventilated. Anesthesia was
aintained with a 2:1 O2/N2O gas mixture and 2%
soflurane. Leads were placed on both hind limbs
or detecting the electrocardiogram of the trans-
lanted heart in the abdomen. Body temperature
as maintained at 36.5  1°C using a rectal probe
dels
r working heart model. Arrows indicate directions of the blood
nastomosis model (A) has insufﬁcient loading, via gurgitation
ading via the inferior vena cava (IVC) and can pump against the
 left ventricle; RA  right atrium; Rt. Lung  donor right lung;
s
ve values) and radial thickening (Err) (dotted lines, all positive
plotted within a cardiac cycle. Strains from 6 short-axis slices areMo
cula
le-a
r lo
; LVeart
gati
are
shown: 2 apical (Ape) slices (brown and dark red), 2 mid-level (Mid) slices (red and orange), and 2 basal (Bas) slices (yellow-orange and
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734nd water pad with a feedback-controlled circulat-
ng water bath.
In vivo CMR was carried out on a Bruker
iospec 4.7-T/40-cm system equipped with 12-cm,
0-G/cm shielded gradients with a 5.5-cm home-
uilt surface coil. Electrocardiogram and respiration-
ated T2*-weighted images were acquired with a
radient-echo sequence, and tagging was achieved
ith a modified DANTE sequence. Ten short-axis
lices were used to cover the entire volume of the
eart. Equivalent temporal resolution for the cine
oops was about 16.5 to 19.5 ms per frame, with 10
o 12 phases per cardiac cycle. Magnetic resonance
mages were acquired with the following parame-
ers: repetition time: 1 cardiac cycle (180 ms);
cho time: 4 to 5 ms for tagging and 8 to 10 ms for
2*-weighted imaging; field of view: 3 to 4 cm; slice
hickness: 1 to 1.5 mm; in-plane resolution: 117 to
56 m.
istological analysis and evaluation of rejection grade.
he degree of rejection was determined by patho-
ogical examination immediately following the
MR studies. Transplanted hearts were extirpated
nd fixed in 10% formalin. The rejection grade of
he heart grafts was determined histopathologically
ccording to the updated International Society for
eart and Lung Transplantation criteria (17,18) in
blinded manner by the Transplantation Pathology
aboratory of the University of Pittsburgh Medical
enter.
train and wall-motion analysis. Strains are values
hat quantify the extent of ventricular deformation
Figure 3. Pathology for Transplanted Hearts
Hematoxylin and eosin staining for an isograft heart (A) and allogra
POD5 (D), POD6 (E), and POD7 (F). On POD 3, the allograft myocar
ally loses its integrity as more cellular inﬁltration occurs when rejechroughout cardiac phases: stretching/elongation or (ompression/shortening. Strains are categorized
nto 2 main classes in relation to the heart axes:
ormal strains are defined in relation to the
hort-axis planes, and principal strains are de-
ned in relation to the direction of the myocar-
ial fiber bundles. Three orthogonal strain-tensor
ets define normal strains: circumferential strains
Ecc), radial thickening (Err), and longitudinal
hortening (Ell), in which strain-tensors are tan-
ent to the epicardium surface, perpendicular to
he epicardium surface toward the center of the
V, and perpendicular to the short-axis plane
long the long-axis of the LV, respectively. Three
rthogonal strain-tensor sets define principal
trains: E1 is orthogonal to the fiber direction; E2
s parallel to the fiber direction; and E3 is
erpendicular to these two. Only 4 of the 6
train-classes are calculated for the transplanted
earts in this study because the through-plane
otions are not observed by the short-axis,
ulti-slice, 2-dimensional-tagged CMR used in
his study.
Strains were analyzed by the harmonic phase
ethod (HARP) (19) with software obtained from
iagnosoft, Inc. (Morrisville, North Carolina). Al-
hough the harmonic phase method is capable of
alculating strains in all 3 heart layers (epicardium,
id-wall, and endocardium), only the mid-wall
ayer values are used in this study, because the
ecent MESA (Multi-Ethnic Study of Atheroscle-
osis) study showed that the mid-wall layer yields
he best interobserver and intraobserver consistency
earts harvested on post-operational day (POD)3 (B), POD4 (C),
is largely intact as isograft controls, but the myocardium gradu-
progresses.ft h
dium20).
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735tatistical analysis. The results are presented as
ean  SD. All results were analyzed by a 2-tailed
test.
E SULTS
racking macrophage inﬁltration in vivo with USPIO
abeling. Cells can be visualized with CMR by
abeling them with contrast agents such as USPIO.
ron-oxide particles generate local magnetic field
radients, and the loss of water proton spin coher-
nce can be detected as signal loss in T2*-weighted
mages.
One day after administration of USPIO, accu-
ulation of labeled immune cells was identified as
atches of hypointensity on T2*-weighted images of
llograft hearts (Figs. 4C to 4E). Histological ex-
mination indicates that iron particles are mostly
ound in ED1 macrophages (9–12). The T2*-
eighted images of isograft control hearts display
ittle or no areas of hypointensity (Figs. 4A and 4B).
n this in vivo-labeling scheme, both residing and
irculating macrophages can ingest USPIO particles.
Macrophage-infiltrated foci, in both the left and
ight ventricles, are found to be spatially heteroge-
eous. It is, therefore, not surprising to find dis-
repancies in diagnosing rejection with biopsy,
here the small biopsy needles are generally limited
o sampling points in the anteroseptal wall of the
ight ventricle. Tracking immune-cell infiltration
ith CMR is noninvasive and provides 3-dimensional
hole-volume perspectives of the overall rejection
tatus without the pitfalls of limited sampling.
racking regional functional loss in vivo with tagged
MR and strain analysis. To discern if the spatial
eterogeneity of acute rejection after heart trans-
lantation is also manifested in ventricular function,
agged CMR was used during the same imaging
ession as the cellular imaging to detect regional
all-motion abnormality.
Figure 4. T2*-Weighted Image Showing USPIO-Labeled Immune
(A, B) Isografts, (C, D) grade III allografts, and (E) grade II allograft.
superparamagnetic-iron-oxide (USPIO)–labeled immune cells. The u
the abdomen. Tx Lung  transplanted lung; other abbreviations as in FTagged CMR (Fig. 5) places signal-void grids on
he myocardium at end-diastole by saturating pro-
on spins at designated planes in space before the
maging sequence. Because the rate of the signal
ecovery is slower than the cardiac motion, these
agged lines (signal-void grids) remain during the
ardiac cycle and serve to mark the motion of the
yocardium. Tagged lines in a healthy heart show
aximum displacement and curvature at end-
ystole throughout the LV wall, as observed in
ative hearts (Fig. 5F) and isograft controls (Fig.
G). In allograft hearts, although ejection fraction
emains close to 95%, some tagged lines do not
how similar displacement or remain straight at
nd-systole, revealing areas with compromised wall
otion (Figs. 5H to 5J).
The extent of tissue deformation observed by
agging can be quantified by strain analysis. Four
train types were analyzed, however, only the Ecc
train (tangent to the epicardium surface) is shown
n this article due to space limitations. Figure 6A
hows mean Ecc values for transplanted hearts with
ifferent degrees of rejection. Although global car-
iac functional parameters, such as stroke volume
Fig. 6B) or ejection fraction (Fig. 6C), do not
egrade according to rejection grades very much,
llografts with rejection greater than grade II all
how a decrease in mean Ecc. This is indicative that
train analysis could be a more sensitive measure of
unction than conventional modes of evaluating
ardiac function. However, mean Ecc is poor at
iscriminating between grade II and grade III
ejection.
To investigate regional strain, the LV wall is
ivided into 6 regions (Figs. 7 and 8A), following
he standard cardiology convention. Isografts (Fig.
A) exhibit consistent Ecc throughout different
ubregions of the LV wall. Allografts (Figs. 7B and
C) exhibit healthy strains in some regions, but
l Inﬁltration in Transplanted Hearts
hes of hypointensity indicate areas with high numbers of ultra-small
left corner of the isograft in (A) has a susceptibility artifact fromCel
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736ompromised strains in other areas, showing that
he functional loss in rejection is heterogeneous.
espite having similar mean Ecc, grade III (Fig.
C) allografts have more regions with compromised
trains than grade II (Fig. 7B) allografts do and can
hus be distinguished. Regional strain analysis is
herefore a more sensitive way to dissect regional
ysfunction and rejection grade than global func-
ional parameters.
However, unlike coronary artery disease, rejec-
ion does not necessarily follow certain coronary
rtery perfusion domains, and as a result, the actual
henomenon might be lost in the conventional
-heart-region division. Thus, starting at the inter-
eption with the right ventricle on the anterior wall,
Figure 5. CMR Tagging
Tagged images for a native heart (A, F) and the same transplant
shown in Figure 4A; (C, H) are the allograft shown in Figure 4C;
graft shown in Figure 4E. (Top panels, A to E): end-diastole; (low
wall motion are identiﬁed with arrows. Some areas with the USP
Anatomical structures are not labeled for clarity. Refer to Figure
nance; other abbreviations as in Figure 4.
Figure 6. Mean Ecc, SV, and EF for Native and Transplanted He
Mean Ecc (A), stroke volume (SV) (B), and ejection fraction (EF) (C)
orange), allograft grade I (G1, orange), grade II (G2, red), grade III
values of Ecc strain are used without negative signs. Abbreviations as in8 probe points were placed evenly throughout the
V mid-wall to further dissect regional function.
igure 8B shows a polar plot of probe-point Ecc
alues at different rejection grades. The isograft
ontrol shows relatively consistent Ecc throughout
he whole LV wall, whereas allografts have some
tretches of probes exhibiting compromised low Ecc
alues.
The severity of rejection correlates with the
umber of compromised probe points. Figure 9A
raphically shows examples of compromised Ecc
robe points at different rejection grades. Probe
oints are scored as compromised (solid bars) if the
cc value is lower than 1 SD from the isograft
ean. Figure 9B shows the Ecc strain index (per-
earts shown in Figure 4. Images (B, G) are the same isograft
I) are the allograft shown in Figure 4D; and (E, J) are the allo-
panels, F to J): end-systole. Some areas with compromised
abeled macrophage inﬁltration can be seen as dark regions.
bels for corresponding hearts. CMR  cardiac magnetic reso-
ative and transplanted hearts: native (yellow), isograft (yellow-
dark red), and grade IV (G4, brown). |Ecc|: absolute or positiveed h
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4 laarts
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(G3,Figure 2.
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737entage of compromised probe points) for trans-
lanted isograft and allograft hearts. A high score
ndicates poor ventricular function that can be
eadily correlated with rejection grade.
imultaneously tracking regional functional loss
nd immune-cell inﬁltration in the same heart by
n vivo CMR. Figure 10 shows examples of non-
nvasive tracking of both immune-cell infiltration
left 2 columns) and regional wall motion (right 2
olumns) at the same time. Pseudocolors (Figs.
0D to 10F) are placed on top of the T2*-
eighted CMR (Figs. 10A to 10C) to show
egions having USPIO-labeled immune-cell in-
ltration. The Ecc-strain values are color coded
n tagged images (Figs. 10G to 10I). In addition,
cc values obtained by the 48 probe points are
lso plotted (Figs. 10J to 10L) for comparison.
lthough some areas with high USPIO-labeled
acrophage infiltration seem to largely correlate
ith areas with compromised Ecc, the subnormal
reas with the 2 modalities do not seem to match
ompletely.
Although the signal- and contrast-to-noise
atios from T2*-weighted images do not always
xhibit a positive correlation with rejection
rades, the areas identified as having USPIO-
aden macrophage infiltration (Fig. 11A) do in-
rease up to a moderate rejection grade, with no
urther increase observed from moderate rejection
o severe rejection. Although both the volume
ith USPIO-laden macrophage infiltration and
cc values do not correlate perfectly with rejec-
ion grades, they do correlate in the same heart
Fig. 11B). Regardless of the rejection grades, the
earts with higher infiltration volume exhibit
Figure 7. Regional Ecc for Different Heart Regions
Deﬁnition of the 6 segmented regions: R1  anterior; R2  anterio
septal (right coronary artery); and R6  anteroseptal (left anterior d
age for all regions. (A) grade I; (B) grade II; (C) grade III. |Ecc|: absol
Brown bars  isograft controls; orange bars  allografts.ower Ecc values in most cases. UI SCUS S ION
onitoring acute allograft rejection with CMR has
he advantage of being noninvasive and providing
-dimensional information on the whole heart,
hereas biopsy is restricted to limited tissue sam-
les. Our 2-pronged approach of monitoring both
mmune-cell infiltration and organ function simul-
aneously can better diagnose episodes of acute
llograft rejection.
It is known that discrepancies are observed
linically among biopsy, rejection, and organ
ysfunction, even with the updated and improved
athological grading system (4). Variation could
e due to subjective interpathologist interpreta-
ion. Alternatively, one may argue that mononuclear-
ell infiltration may not be the only mechanism of
cute cardiac rejection (8). Interestingly, our data
eveal a different observation and explanation, namely
hat the infiltration of immune cells is highly hetero-
eneous, even in grade III rejection. The
ononuclear-cell infiltration can be expected to be
ven more sparse and inhomogeneous at earlier rejec-
ion phases (10). Therefore, biopsy with finite sam-
ling sizes can miss the infiltrated sites, resulting in
alse diagnosis and a discrepancy between biopsy,
ctual rejection, and organ dysfunction. Because
MR can cover the whole volume of the heart,
onitoring immune-cell infiltration with CMR could
eveal overall distribution of mononuclear cells. Our
pproach of monitoring mononuclear-cell infiltration
n vivo with CMR is not only noninvasive, but also
otentially can provide a more accurate diagnosis. In
ombination with automated algorithms for detecting
al (left circumﬂex artery); R3  lateral; R4  inferior; R5  inferio-
nding artery). Refer to Figure 8A for drawing. “Whole” is the aver-
or positive values of Ecc strain are used without negative signs.later
esce
uteSPIO-laden mononuclear-cell infiltration foci (21),
o
n
b
i
d
m
v
f
s
o
v
l
t
c
t
r
p
a
v
p
p
t
T
t
i
c
f
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 2 , N O . 6 , 2 0 0 9
J U N E 2 0 0 9 : 7 3 1 – 4 1
Wu et al.
Noninvasive Monitoring Cardiac Rejection by CMR
738ur approach may make accurate and objective diag-
osis of cellular rejection possible.
At the dosages used clinically, USPIOs have
een shown to possess low toxicity, and the iron
s metabolized by incorporating into normal en-
ogenous iron pools (22). Immune cells, mainly
acrophages, are readily labeled by direct intra-
enous administration of USPIO, with no need
or cell isolation or culture. This in vivo labeling
trategy also avoids possible unwanted activation
f immune cells, if cells are isolated, labeled ex
ivo, and reintroduced into patients. This in vivo
abeling approach is simple and makes clinical
ranslation much more feasible than the ex vivo
Figure 8. Local Ecc for Different Heart Locations
(A) Drawing of 6 heart regions. R1  anterior; R2  anteriolateral (
anterioseptal (LAD). (B) 48 probe-points are placed throughout the
probes 25 to 32 (R4), probes 33 to 40 (R5), probes 41 to 48 (R6). |Ec
line  averaged Ecc for isografts; yellow triangle  Grade I allogra
red diamond  Grade IV allograft.ell-labeling methods. It is commonly accepted hhat T and B lymphocytes are the dominant cells
esponsible for the rejection and inflammatory
rocesses. However, macrophages are present
bundantly when rejection occurs. We have pre-
iously found that the numbers of both macro-
hages and T cells increase during the rejection
rocess (12,13). Thus, macrophages are a good
arget for in vivo imaging for detecting rejection.
his study and our earlier studies have shown
hat macrophage infiltration is indeed a useful
ndex for acute rejection (9–13), possibly even for
hronic rejection (23).
CMR tagging is a powerful noninvasive tool
or monitoring cardiac wall motion. Our results
; R3  lateral; R4  inferior; R5  inferioseptal (RCA); and R6 
all: probes 1 to 8 (R1), probes 9 to 16 (R2), probes 17 to 24 (R3),
absolute values of Ecc are plotted without negative signs. Black
reen circle  Grade II allograft; blue square  Grade III allograft;LCX)
LV w
c| 
ft; gave shown that regional loss of function is
h
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739ighly heterogeneous, which is not easy to
chieve with other functional and imaging mo-
alities. These results are consistent with clinical
bservations and emphasize that the correlation
f organ dysfunction with acute allograft rejec-
ion is a better indicator of rejection than biopsy
lone (6). Detailed local strain analysis provides a
ensitive way to detect small regional wall motion
bnormality. The harmonic phase method pro-
Figure 9. Rejection Grading by Ecc Probe-Point Values
(A) Numbers of “compromised” probe points for each of the grade
points with compromised Ecc strain appear as solid bars, whereas
probe point is deﬁned as |Ecc| if the particular probe point is lower
promised probe points for individual hearts. Abbreviations as in Fig
Figure 10. Simultaneous Tracking of Cellular Inﬁltration and Fu
(A to C) T2*-weighted CMR; (D to F) pseudo-coloring of T2*-weight
Absolute or positive values of Ecc are indicated; (J to L) polar plots
which is the starting location of probe #1. Abbreviations as in Figures 1ides an easy and fast way for strain analysis,
hich can facilitate high-throughput strain anal-
sis for clinical applications.
Although very informative, the strain maps are
ot straightforward for discerning mildly defec-
ive hearts, because even healthy hearts posses
ome variability in strains throughout different
egions of LV myocardium. By using probe
oints for analysis, areas with compromised
1), grade II (GII), grade III (GIII), and grade IV (GIV) allografts. Probe
e points with normal Ecc strain are open bars. Compromised
n 1 SD from the mean isograft Ecc values. (B) Percentage of com-
2 and 6.
on for 3 Allografts
ages with 8-bit signal intensity scaling; (G to I) Ecc strain maps.
Ecc|. White arrows indicate the intercepted point of RV and LV,I (G
prob
thancti
ed im
of |, 2, 5, and 6.
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740trains can readily be identified; furthermore, the
ercentage of probe points having compromised
cc strain correlates well with rejection grades.
ne standard deviation from mean isograft Ecc
alues is used here as the criteria to distinguish
compromised” and “healthy” probe points.
owever, this criterion obtained from our hete-
otopic model may not be readily applicable for
uman patients with orthotopic transplantation.
dditional human studies to determine criteria
or transplant patients will be necessary to trans-
ate this approach to the clinical setting.
In this study, although 4 different strain types
ere analyzed, only Ecc results are shown due to
pace limitations. There are no obvious differences
n all 4 strain types based on our analysis. Further
etailed analysis could be interesting to see whether
specific strain class is affected more by the rejec-
ion and could be used as the most sensitive
unctional parameter for staging rejection.
Coupling cellular imaging of immune-cell in-
ltration and functional parameters provides ad-
itional power for detecting and grading rejec-
ion. Regional loss in the contractile function
ppears to correlate with the areas of the myo-
ardium found to have significant USPIO-labeled
acrophage infiltration; however, some mis-
atch was found. This mismatch could be due to
echanical, physiological, or electrical reasons.
or example, myocytolysis or degenerated myo-
ardium could physically affect contractile func-
ion of the neighboring myocardium; the contrac-
ile defect from 1 necrotic region could radiate to
Figure 11. Quantitation for USPIO Cell Inﬁltration
(A) Percentage of contrast-containing-volume from T2*-weighted im
grade III (dark red), and grade IV (brown) allografts. (B) Plot percen
vidual heart slices for isografts (yellow-orange crosses), grade I (or
and grade IV (brown triangles) allografts. The Ecc and USPIO volum
For each allograft plotted, Ecc and USPIO volumes were obtained frarger remote areas through connecting myocar- iial fiber; or electrical conductivity could be
indered or interrupted by the necrotic regions.
ome mismatch found here may also result from
ixel mismatch between the 2 methods. Better
omputational algorithms for precise pixel-by-
ixel analysis and a larger sampling group will be
eneficial for understanding the more detailed
iomechanics of rejection.
Signal- and contrast-to-noise ratios correspond
ith the amount of contrast agent found in the
issue; however, the number of iron-labeled cells
hat have accumulated in an image voxel is inher-
ntly difficult to quantify by T2*-contrast. In addi-
ion, the degree of immune-cell labeling by direct in
ivo injection of contrast agent is not well con-
rolled. These drawbacks, however, do not limit our
ethod, because our results indicated that the
bsolute amount of cell infiltration may not be
mportant for staging rejection by CMR. We have
ound out that the percentage of contrast-
ontaining-volume may be very useful for discern-
ng areas with labeled cell infiltration. Furthermore,
lthough the extent of labeled cell infiltration and
cc strain reduction themselves show some varia-
ions, the transplanted hearts with more labeled cell
nfiltration exhibit poorer Ecc strains in most cases.
his further testifies the advantage of using a
-parameter diagnosis.
ONCLUS IONS
ur results suggest that myocardial rejection is
patially highly heterogeneous, for both cellular
s for isografts (yellow-orange), grade I (orange), grade II (red),
e of contrast-containing-volume against mean Ecc strain for indi-
diamonds), grade II (red squares), grade III (dark red circles),
for isografts were obtained from different animals in some cases.
the same animal. Abbreviations as in Figures 2 and 4.age
tag
ange
esnfiltration and myocardial function. The immune-
c
w
r
t
c
t
d
v
r
s
t
f
R
p
v
R
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 2 , N O . 6 , 2 0 0 9
J U N E 2 0 0 9 : 7 3 1 – 4 1
Wu et al.
Noninvasive Monitoring Cardiac Rejection by CMR
741ell-infiltrated foci can be detected noninvasively
ith in vivo USPIO labeling of immune cells, and
egional functional loss can be determined by CMR
agging and wall-motion analyses. This proof-of-
oncept study of our two-pronged approach illus-
rates a potentially sensitive diagnostic tool for
etecting acute cardiac rejection. A systematic in-
estigation with a larger sample size and differentapproach to detecting organ rejection MC, et al. Revisionet of clinically relevant indexes. Monitoring rejec-
ion by CMR can be a better and safer alternative
or routine rejection surveillance than biopsy.
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